This approach is underpinned by our ability to rapidly gain a deeper understanding of disease biology and identify a wealth of potential drug targets that may hold the keys for unlocking new treatments and potential cures.
This approach is underpinned by our ability to rapidly gain a deeper understanding of disease biology and identify a wealth of potential drug targets that may hold the keys for unlocking new treatments and potential cures. We are using a multi-pronged approach – investing in genomics, data science and AI, next-generation sequencing and CRISPR gene editing – to identify, interrogate, and validate new targets in a way not previously thought possible. Each new insight and every new piece of information brings us closer to creating better, more advanced and more effective treatments for patients.